CHI3L1 and amyotrophic lateral sclerosis: For example, CSF chitinases have emerged as markers of neuroinflammation in patients with ALS with higher CSF CHIT1, CHI3L1 and CHI3L2 associating with faster disease progression, greater cognitive dysfunction and/or shorter survival [143–147].